Supplements Exposed: What Really Works for Prostate Health

DrTalks

G. Espinosa

Microultrasound vs. MRI-Guided Biopsy for Prostate Cancer Diagnosis …

Laurence Klotz

Year in Review: Prostate Cancer - 2024 Insights and Exciting Prospec…

Jason Hafron

Prostate Cancer Diagnosis Pathway: 2024 Update

Anwar Padhani

A. Padhani

Prostate Cancer Ablation - The Best Option For Your Intermediate Ris…

Preston Sprenkle

Prostate Cancer Detection: MRI, Image Quality, and PI-RADS Techniques

International Cancer Imaging Society (ICIS)

P. Asbach

Year in Review - Prostate Cancer

Oncology 2024 Year in Review

K. Tawagi

Robot-Assisted Radical Prostatectomy: Surgical Techniques and Sexual…

RENALC-BLADDR-PROSCA 2024

A. Tewari

Year in Review 2024 - Managing Advanced Prostate Cancer

Oncology 2024 Year in Review

R. Dreicer

The HERO Trial: Relugolix vs. Leuprolide in Advanced Prostate Cancer

Duke Cancer Institute

D. George

Year in Review - Key Clinical Trials in Prostate Cancer

GWU Urology

Focal Therapy for Prostate Cancer: the Past, Present and Future

Focal Therapy Society

T. Polascik

Prostate Cancer Detection with MRI and Biomarkers

DrTalks

S. Punnen

Cancer Screening in Primary Care: An Evidence-Based Review of Outpat…

UNC Lineberger Comprehensive Cancer Center

N. Robertson

EAU25 Insights: PSMA-radioguided Surgery in Locally Recurrent Prosta…

Tobias Maurer

Ideal Treatment Sequence After ADT + ARPI + Docetaxel for mHSPC

Advanced Prostate Cancer Consensus Conference (APCCC)

K. Fizazi

2L Treatment Options and Decision-Making Considerations in mCRPC Man…

Andrew Armstrong

ASCO® GU 2025 Insights: The Influence of Boosting Gut Health and Phy…

Insights from 2025 ASCO® GU Annual Meeting

R. Thomas

Enhanced Diagnostics in Prostate Cancer: PSA and Beyond in 2024

Penn Medicine Abramson Cancer Center

D. Lee

Practical Considerations for PSMA-Targeted Therapy in Prostate Cancer

University of Illinois Cancer Center

K. Tawagi, N. Reizine